Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

August 16, 2018

Study Completion Date

January 25, 2019

Conditions
Sebum ProductionStool MicrobiomeTransepidermal Water LossFacial BrrightnessErythemaWrinklesFacial Shine
Interventions
DIETARY_SUPPLEMENT

Placebo Oral Tablet

"Group A: Placebo group (n = 10)~* Supplement appearing similar to Herbal formulations~* Each placebo tablet will contain microcrystalline cellulose, dicalcium phosphate, PVPK30, sodium starch glycolate, magnesium stearate, OpaDry orange coating.~* Dose: subjects in this group will take 4 placebo tablets per day"

DIETARY_SUPPLEMENT

Rubia Cordifolia

"Group B: R. cordifolia group (n = 10)~* 2,000 mg R. cordifolia per day - supplied by Banyan Botanicals and following standard supplementation doses on commercially available supplement (https://www.banyanbotanicals.com/manjistha-tablets/)~* Each tablet contains 500 mg of R. cordifolia per tablet."

DIETARY_SUPPLEMENT

Triphala

"Group C: Triphala group (n= 10)~* Tablets of Triphala will be supplied from Banyan Botanicals (https://www.banyanbotanicals.com/triphala-tablets-11/)~* Each tablet contains mix Emblica officinalis, Terminalia bellerica, and Terminalia chebula~* Dose: subjects will take 4 tablets per day, with a total dose of 2,000 mg of total herb."

Trial Locations (1)

95816

University of California-Davis, Department of Dermatology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT03477825 - Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin | Biotech Hunter | Biotech Hunter